Amgen Innovator Series
September 1, 2016 Alejandro Tocigl CEO, Miraculous Miroculus provides decentralized, affordable, non-invasive molecular diagnostics by leveraging blood circulating microRNAs and a proprietary digital [...]
Amgen Incubators Grow Startup for Harvest
Venture division seeks access to technology, potential takeovers. San Fernando Valley Business Journal, July 11-24, 2016 By STEPHANIE HENKEL, Staff Reporter Amgen inc. hopes to get in on more ground f [...]
Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration
Using Molecular ‘On/Off Switches’ for CAR T-Cell Immunotherapies Kite to License Cell Design Labs’ Synthetic Biology Technology for Applications in Acute Myeloid Leukemia with Exclusive Option for App [...]
Cell Design Labs Executes Series of Private Financings
New Company Focused on Discovering and Developing Next-Generation Immunotherapies for Cancer and Other Complex Diseases SAN FRANCISCO, Calif. June 2, 2016 - Cell Design Labs, Inc. today announced it h [...]
Avant Completes Acquisitions of Amarantus and Theranostics Health
Avant Diagnostics announced today that it has completed its previously announced acquisitions of Amarantus Diagnostics and protein analysis services provider Theranostics Health. In January, Scottsdal [...]
ViewPoint Therapeutics Raises $4 Million in Series A Financing
ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of [...]
Miroculus Acquires Microfluidics Firm Kapplex
Miroculus, a San Francisco startup developing microRNA-based diagnostic tests, said Monday that it has acquired Toronto-based microfluidics firm Kapplex for an undisclosed amount. Miroculus emerged fr [...]
Perlstein Lab continues their rare disease drug discovery
Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they c [...]
Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con
Molecular diagnostics startup Miroculus is going all in on microRNAs as the ideal blood-based biomarker for diagnosing and monitoring a number of diseases and even tracking an individual's general phy [...]